During the past decade, Dallas Nephrology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dallas Nephrology Associates" are "Fistula" (2 trials), "AV Fistula" (1 trials), "Arteriovenous Fistula" (1 trials), "Arteriovenous Fistula Occlusion" (1 trials) and "Arteriovenous Fistula Stenosis" (1 trials). Many other conditions were trialed in "Dallas Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Dallas Nephrology Associates" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ellipsys Vascular Access Catheter" (1 trials), "IN.PACT AV DCB" (1 trials), "Merit WRAPSODY Endovascular Stent Graft" (1 trials), "PTA" (1 trials) and "Standard Balloon Angioplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Nephrology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Nephrology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dallas Nephrology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".